| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/08/2002 | CA2434953A1 Protein modification and maintenance molecules |
| 08/08/2002 | CA2434808A1 Novel mixtures of microbial enzymes |
| 08/08/2002 | CA2434097A1 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii |
| 08/08/2002 | CA2432981A1 Use of fredericamycin a and its derivatives in the treatment of pin1-associated states |
| 08/08/2002 | CA2432867A1 A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | CA2432731A1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 08/08/2002 | CA2432278A1 Methods and compositions relating to cardiac-specific nuclear regulatory factors |
| 08/08/2002 | CA2430921A1 Use of a vector encoding a ghrh peptide to enhance growth in multiple litters of offspring from female animals |
| 08/08/2002 | CA2429359A1 Hepatitis c tripeptide inhibitors |
| 08/08/2002 | CA2427143A1 Compositions and methods for improving kidney function |
| 08/08/2002 | CA2426587A1 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans |
| 08/08/2002 | CA2426582A1 Gene delivery formulations and methods for treatment of ischemic conditions |
| 08/07/2002 | EP1229132A2 Human ralgds-like protein 3 |
| 08/07/2002 | EP1229122A2 Chimeric isoprenoid synthases and uses thereof |
| 08/07/2002 | EP1229115A1 Novel c-type lectin and gene thereof |
| 08/07/2002 | EP1229048A1 Thromboplastin reagent and method for manufacturing the same |
| 08/07/2002 | EP1229046A2 Human testis expressed patched like protein |
| 08/07/2002 | EP1229045A1 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 08/07/2002 | EP1229043A1 Peptides derived from Epstein Barr virus (EBV) proteins LMP1, LMP2 and BARF1 antibody reagents reactive therewith |
| 08/07/2002 | EP1229042A1 Cyclic peptides and aids vaccines |
| 08/07/2002 | EP1228769A1 Symbiotic regenerative composition |
| 08/07/2002 | EP1228767A1 Use of beta-Glucuronidase for the treatment of immune or allergic diseases |
| 08/07/2002 | EP1228766A1 PYK2 phosphorylation by HER3 induces tumor invasion |
| 08/07/2002 | EP1228708A2 Milk derived basic protein fraction as agents for improving lipid metabolism and reducing high blood pressure |
| 08/07/2002 | EP1228707A1 Use of alpha-lactalbumin as prebiotic agent |
| 08/07/2002 | EP1228373A2 Diagnosis and therapy of cancer using sgp28-related molecules |
| 08/07/2002 | EP1228236A2 Compositions for transfecting nucleic acids and their use |
| 08/07/2002 | EP1228235A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/07/2002 | EP1228231A1 Mammalian-type glycosylation in plants |
| 08/07/2002 | EP1228222A2 Human transferase molecules |
| 08/07/2002 | EP1228217A2 Conserved neisserial antigens |
| 08/07/2002 | EP1228214A2 Erythropoietin forms with improved properties |
| 08/07/2002 | EP1228213A2 Protein having activity as an angiogenesis modulator |
| 08/07/2002 | EP1228208A2 36p6d5: secreted tumor antigen |
| 08/07/2002 | EP1228205A2 Twik potassium channel molecules and uses therefor |
| 08/07/2002 | EP1228204A2 Smad associating polypeptides |
| 08/07/2002 | EP1228203A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 08/07/2002 | EP1228202A2 Antisense compositions and cancer-treatment methods |
| 08/07/2002 | EP1228201A1 High order nucleic acid based structures |
| 08/07/2002 | EP1228097A2 Antimicrobial activity of the first cationic cluster of human lactoferrin |
| 08/07/2002 | EP1228095A1 Modified gp100 and uses thereof |
| 08/07/2002 | EP1228093A2 Improvement of peptide transport by conjugation with bile acids |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228091A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 08/07/2002 | EP1228090A2 Novel molecules and the card-related protein family and uses thereof |
| 08/07/2002 | EP1228089A2 Salt form of a conjugate useful in the treatment of prostate cancer |
| 08/07/2002 | EP1228088A2 Novel traf family proteins |
| 08/07/2002 | EP1228086A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 08/07/2002 | EP1228085A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 08/07/2002 | EP1228082A1 29 human secreted proteins |
| 08/07/2002 | EP1228076A1 A substantially cell membrane impermeable compound and use thereof |
| 08/07/2002 | EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 08/07/2002 | EP1228028A1 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 08/07/2002 | EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 08/07/2002 | EP1227838A2 Melanoma vaccine and methods of making and using same |
| 08/07/2002 | EP1227837A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 08/07/2002 | EP1227835A1 Protease inhibitors as modulators of periodontal wound healing |
| 08/07/2002 | EP1227834A2 Use of caspase-14 and caspase-14 modulators to diagnose and/or treat skin, eye and brain disorders |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227832A2 Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene |
| 08/07/2002 | EP1227831A2 Interferon gamma for the treatment of asthma |
| 08/07/2002 | EP1227830A1 Method of inducing angiogenesis |
| 08/07/2002 | EP1227829A2 Novel chimeric analgesic peptides |
| 08/07/2002 | EP1227828A1 Viruses for the treatment of cellular proliferative disorders |
| 08/07/2002 | EP1227824A1 Transplant/implant device and method for its production |
| 08/07/2002 | EP1227823A2 Methods for inducing (in vivo) proliferation and migration of transplanted progenitor cells in the brain |
| 08/07/2002 | EP1227821A1 Therapeutic compositions and methods of use thereof |
| 08/07/2002 | EP1227814A1 Hormonal composition based on a progesterone and an oestrogen and use thereof |
| 08/07/2002 | EP1227813A1 Reverse-turn mimetics and methods relating thereto |
| 08/07/2002 | EP1227794A2 Method for encapsulating proteins or peptides in liposomes, liposomes produced using said method, and their use |
| 08/07/2002 | EP1227793A1 Cyclosporin formulation |
| 08/07/2002 | EP1227736A1 Protein hydrolysates produced with the use of marine proteases |
| 08/07/2002 | EP1227734A2 Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein |
| 08/07/2002 | EP1181352A4 Versican and epithelial-mesenchymal interaction |
| 08/07/2002 | EP1019016B1 Active synergetic complex and cosmetic and/or pharmaceutical product containing this complex |
| 08/07/2002 | EP0914081B1 Storage stable dentifrice composition containing casein glycomacropeptide |
| 08/07/2002 | EP0912097B1 Antimicrobial peroxidase compositions |
| 08/07/2002 | EP0906576B1 Prostate cancer specific antibodies for immunodetection and immunotherapy |
| 08/07/2002 | EP0835265B1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues |
| 08/07/2002 | EP0828478B1 Osmotic device with delayed activation of drug delivery and complete drug release |
| 08/07/2002 | EP0823257B1 Medicinal composition for curing thrombocytopenia |
| 08/07/2002 | EP0809517B1 Anti-transforming growth factor-beta gene therapy |
| 08/07/2002 | EP0805690B1 Method for selective methionine starvation of malignant cells in mammals |
| 08/07/2002 | EP0748217B1 Compositions comprising a mast cell degranulation-blocking h-1 receptor antagonist for the treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin |
| 08/07/2002 | EP0584245B1 Enzyme systems |
| 08/07/2002 | CN1362970A Monoclonal antibody against estrogen-stimulated leucine aminopeptidase |
| 08/07/2002 | CN1362969A Antimicrobial/endotoxin neutralizing polypeptide |
| 08/07/2002 | CN1362968A Novel peptides |
| 08/07/2002 | CN1362967A Modulators for beta-amyloid peptide aggregation comprising D-amino acids |
| 08/07/2002 | CN1362966A Pseudomycin amide and ester analogs |
| 08/07/2002 | CN1362883A Stable composition comprising epidermal growth factor as active ingredient |
| 08/07/2002 | CN1362880A Immunomodulating polymers |
| 08/07/2002 | CN1362417A Zinc-binding-force reinforced insulin derivative |
| 08/07/2002 | CN1362416A Production process of epidermal cell inhibitor with animal skin and its use |
| 08/07/2002 | CN1362263A Recombinant protein vaccine for preventing and treating human prostata cancer |
| 08/07/2002 | CN1362262A Beaver thymosin injection and its prepn |
| 08/07/2002 | CN1088721C Interferon conjugates |
| 08/07/2002 | CN1088706C Novel heterocyclic amide compounds and medicinal uses thereof |
| 08/07/2002 | CN1088606C Centrifuger with annular filter |
| 08/07/2002 | CN1088597C Uropoly acid-peptide composition and its usage |